Cargando…
NESTROFT—A Cost-Effective Mass Screening Tool for the Detection of β-Thalassemia Carrier Status in Anemic Pregnant Women: A Step Toward Reducing the National Disease Burden
Introduction β-Thalassemias are inherited hemoglobinopathies commonly encountered in practice. With chances of a promising cure being rare, the prevention of births with this disorder should assume priority, especially in low-resource countries. This can be achieved by the implementation of a mass s...
Autores principales: | Gosavi, Manasi, Chavan, Ramesh, Bellad, M. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714408/ https://www.ncbi.nlm.nih.gov/pubmed/34975258 http://dx.doi.org/10.1055/s-0041-1732493 |
Ejemplares similares
-
Determinants for Anemic Retinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023) -
Biochemical and hematological changes among anemic and non-anemic pregnant women attending antenatal clinic at the Bolgatanga regional hospital, Ghana
por: Ahenkorah, Benjamin, et al.
Publicado: (2018) -
Thalassemias: can we reduce the national burden?
por: Colah, Roshan
Publicado: (2014) -
Population Pharmacokinetics and Exposure‐Response Relationship of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With β‐Thalassemia
por: Chen, Nianhang, et al.
Publicado: (2020) -
Perinatal outcomes in anemic pregnant women in public hospitals of eastern Ethiopia
por: Debella, Adera, et al.
Publicado: (2022)